It seems bizarre that at the time of writing, we are into the fourth month of a viral pandemic, and yet only one of many available disinfectant and hand sanitiser chemistries had been tested against SARS-CoV-2 coronavirus. Andrew Kemp explains.
The NHS has announced that heparin is to be trialled on critically-ill COVID-19 patients, putting more pressure on laboratories to set up new anti-Xa assay protocols. Stago UK is able to help remotely using its Connect.One data sharing middleware.
Black and south Asian ethnic groups in England appear to be at higher risk of SARS-CoV-2 infection and COVID-19, as well as hospitalisation with the disease, according to new UK Biobank research.
The University of Glasgow and NHS Greater Glasgow & Clyde (NHSGGC) are supporting the University of Oxford’s SARS-CoV-2 coronavirus vaccine trials in health and care staff. The collaboration is part of the University of Oxford’s Phase III of the trial, which involves assessing health and care staff living in Greater Glasgow and Clyde, who will be invited to take part in the trial if they are aged 18–55 years, healthy and have not been infected with SARS-CoV-2.
Effective and reliable solutions to detect SARS-CoV-2 are urgently needed, and antibody-based serological assays are a sensitive way to diagnose infection. Dr Pei Liu (Senior Scientist, Antibody Department, GenScript) will lead a free webinar on 2 June 2020 (10.00 am EST [3.00 pm BST] and 1.00 pm EST [6.00 pm BST]). Click on this story to access the link to register.
CE marking has been granted to whole-pathogen quality controls for SARS-CoV-2, from global diagnostics company Randox Laboratories. The molecular controls are currently being used alongside the firm’s coronavirus tests, performed on its proprietary Biochip, as part of a nationwide UK testing programme.
EKF Diagnostics has secured new contracts for the manufacture and supply of a novel, patented sample collection device which allows SARS-CoV-2 coronavirus samples to be rapidly inactivated in the collection tube, avoiding contamination and preserving RNA without need for refrigeration. To support the increase in testing globally, a safe and easy sample collection and transport mechanism is essential, and this is provided by the PrimeStore MTM sample collection device.
Siemens Healthineers is expanding its infectious disease testing capabilities to aid in the SARS-CoV-2 pandemic. Recognising the critical need for accurate diagnostic testing, the company has developed a laboratory-based total antibody test to detect the presence of SARS-CoV-2 antibodies in blood.
The current pandemic has created a demand for test kits that can be run with less amount of reagents while generating faster test results. Lumex Instruments’ microchip real-time PCR analyser, AriaDNA, by detecting SARS-CoV-2, has proven its ability to meet this demand. The Microchip RT-PCR coronavirus detection system based on AriaDNA can test up to seven patient samples in one run, which takes less than an hour, with low reagent consumption.
IDvet, a company specialising in the development and production of diagnostic tests for the detection of infectious diseases in farm animals, has announced the commercial launch of a SARS-CoV-2 antibody test for humans.
In the first of a new webinar series, University of Birmingham experts will discuss how research can help people living in low- and middle-income countries (LMICs) to stay safe during the current coronavirus pandemic. Click on this story to registration for this free webinar, to be held on Thursday 21 May.
A serological screening machine with a claimed capacity of up to 3000 tests a day that produces results in 35 minutes with 99.8% accuracy has been developed by Quotient in Scotland and Switzerland. The blood-screening firm is now keen to hold talks with UK ministers amid interest from Europe for the machines.
The British In Vitro Diagnostics Association (BIVDA) has commented on recent media headlines as testing continues to underpin the fight against the SARS-CoV-2 coronavirus.
New antibody test kits for ongoing SARS-CoV-2 coronavirus testing and immunity research are now being manufactured in Essex. Europlaz Technologies, based in Southminster, has signed an exclusive contract to manufacture antibody test kits.
The International Society on Thrombosis and Haemostasis (ISTH) and European Hematology Association (EHA) are collaborating to present a new webinar on coagulopathy in COVID-19 patients, to be held on 14 May (3.00 pm BST). Click on this story for the link to register for this free webinar.
Avacta Group, the developer of Affimer biotherapeutics and reagents, has shipped Affimer reagents for SARS-COV-2 antigen testing to its diagnostic test development partners. The Group recently reported that it had generated multiple, highly specific Affimer reagents that bind the SARS-COV-2 viral antigen and do not cross-react with SARS, MERS and other closely related coronaviruses.
Stago UK recently hosted a webinar on ‘Coagulation alterations and management of patients with COVID-19 infection’. The presenter, Professor Armando D’Angelo, has been involved in the management of COVID-19 patients in Italy’s Lombardy region, one of the worst affected areas in the world. Click on this story for links to free Stago webinars.
Recently, Proscia made available its Concentriq Dx digital pathology software for use in clinical practice in the USA, following Food and Drug Administration (FDA) guidance to provide a policy to help expand the availability of devices for remote reviewing and reporting of scanned digital images of pathology slides.
The role of unfractionated heparin (UFH) has come to the fore in the battle to save COVID -19 patients. With laboratories facing increased demand to measure anti-Xa activity, Stago UK is offering free enrolment in its Qualiris EQA scheme for UFH, which includes an anti-Xa assay peer group.